HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chen Dong Selected Research

Dual Specificity Phosphatase 1

6/2019Protective Function of Mitogen-Activated Protein Kinase Phosphatase 5 in Aging- and Diet-Induced Hepatic Steatosis and Steatohepatitis.
6/2015Regulation of Adipose Tissue Inflammation and Insulin Resistance by MAPK Phosphatase 5.
3/2015MAPK Phosphatase 5 Expression Induced by Influenza and Other RNA Virus Infection Negatively Regulates IRF3 Activation and Type I Interferon Response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chen Dong Research Topics

Disease

50Neoplasms (Cancer)
08/2022 - 01/2005
48Inflammation (Inflammations)
01/2022 - 11/2005
37Infections
10/2022 - 05/2006
20Autoimmune Diseases (Autoimmune Disease)
01/2021 - 11/2005
12COVID-19
03/2022 - 01/2020
10Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2017 - 06/2003
9Asthma (Bronchial Asthma)
01/2018 - 07/2007
7Colitis
01/2021 - 05/2008
6Virus Diseases (Viral Diseases)
09/2021 - 02/2007
6Insulin Resistance
05/2021 - 05/2015
6Rheumatoid Arthritis
01/2021 - 03/2003
6Hypoxia (Hypoxemia)
01/2020 - 12/2014
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2022 - 04/2009
5Fatigue
08/2022 - 01/2020
5Hypertension (High Blood Pressure)
11/2021 - 01/2019
5Experimental Arthritis
01/2021 - 03/2003
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 06/2006
5Non-alcoholic Fatty Liver Disease
06/2019 - 01/2016
5Lung Neoplasms (Lung Cancer)
05/2018 - 01/2014
4Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 10/2014
4Neoplasm Metastasis (Metastasis)
12/2020 - 10/2007
4Atopic Dermatitis (Atopic Eczema)
01/2020 - 01/2012
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 09/2012
4Mycoses (Diseases, Fungus)
03/2017 - 02/2007
4Hepatocellular Carcinoma (Hepatoma)
12/2016 - 10/2013
4Hepatitis E
04/2016 - 02/2007
4Pneumonia (Pneumonitis)
03/2015 - 05/2009
4Hypersensitivity (Allergy)
02/2013 - 11/2007
3Circulating Neoplastic Cells
10/2022 - 05/2015
3Dysbiosis
01/2022 - 01/2021
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2019
3Wounds and Injuries (Trauma)
01/2022 - 07/2015
3Type 2 Diabetes Mellitus (MODY)
11/2021 - 04/2014
3Ankylosing Spondylitis
08/2020 - 01/2020
3Hyperplasia
01/2020 - 05/2008
3Bacterial Infections (Bacterial Infection)
01/2020 - 09/2013
3Immune System Diseases (Immune Disorders)
01/2018 - 06/2006
3Melanoma (Melanoma, Malignant)
01/2018 - 11/2009
3Diarrhea
12/2017 - 04/2016
3Obesity
01/2017 - 01/2016
3Keratitis
01/2017 - 11/2013
3Schizophrenia (Dementia Praecox)
04/2016 - 02/2013
3Atherosclerosis
10/2014 - 10/2012
2Hepatitis B
07/2022 - 01/2017
2Gout
01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

45Interleukin-17 (Interleukin 17)IBA
01/2021 - 03/2003
44CytokinesIBA
01/2022 - 03/2003
14Proteins (Proteins, Gene)FDA Link
05/2021 - 01/2005
12VaccinesIBA
03/2022 - 02/2007
9Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2007
9AntigensIBA
01/2020 - 12/2009
9LigandsIBA
01/2017 - 09/2007
7AntibodiesIBA
03/2022 - 05/2006
7Immunoglobulin G (IgG)IBA
12/2021 - 03/2003
7AllergensIBA
01/2019 - 07/2007
6Glucose (Dextrose)FDA LinkGeneric
12/2021 - 04/2014
6InterferonsIBA
09/2021 - 01/2012
6Interleukin-4 (Interleukin 4)IBA
01/2018 - 11/2007
6Interleukin-6 (Interleukin 6)IBA
04/2016 - 03/2007
5MicroRNAs (MicroRNA)IBA
01/2022 - 01/2017
5ChemokinesIBA
01/2020 - 11/2005
5Interleukin-23 (Interleukin 23)IBA
03/2019 - 06/2009
4Biological ProductsIBA
10/2022 - 01/2008
44-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
08/2022 - 01/2020
4LipidsIBA
11/2021 - 10/2012
4InterleukinsIBA
01/2021 - 08/2007
4Interleukin-22 (IL-22)IBA
01/2021 - 11/2006
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2016
4Pharmaceutical PreparationsIBA
01/2021 - 07/2011
4Interleukin-17 ReceptorsIBA
01/2021 - 10/2011
4Interleukin-13IBA
01/2020 - 11/2007
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019 - 06/2014
4RNA (Ribonucleic Acid)IBA
11/2018 - 09/2015
4Peptide Hydrolases (Proteases)FDA Link
01/2018 - 05/2009
4Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
10/2017 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
3EnzymesIBA
01/2022 - 10/2016
3Antiviral Agents (Antivirals)IBA
01/2022 - 09/2015
3Indicators and Reagents (Reagents)IBA
01/2022 - 01/2020
3Interleukin-12 (IL 12)IBA
01/2022 - 02/2013
3Interferon Type IIBA
12/2021 - 03/2015
3Alanine Transaminase (SGPT)IBA
11/2021 - 02/2020
3AutoantigensIBA
01/2021 - 04/2017
3Deubiquitinating EnzymesIBA
01/2021 - 09/2015
3Phosphotransferases (Kinase)IBA
04/2020 - 02/2007
3Ubiquitin-Specific ProteasesIBA
01/2020 - 11/2012
3CollagenIBA
06/2019 - 03/2003
3Dual Specificity Phosphatase 1IBA
06/2019 - 03/2015
3Matrix Metalloproteinases (MMPs)IBA
09/2017 - 06/2011
3FlagellinIBA
01/2017 - 11/2013
3Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2017 - 05/2015
3CarbonIBA
01/2016 - 04/2014
3Interleukin-5 (Interleukin 5)IBA
01/2016 - 11/2007
3Interleukin-10 (Interleukin 10)IBA
02/2013 - 11/2006
3interleukin-21 (interleukin 21)IBA
03/2012 - 07/2007
2DNA (Deoxyribonucleic Acid)IBA
10/2022 - 01/2017

Therapy/Procedure

23Therapeutics
01/2022 - 12/2003
16Immunotherapy
01/2022 - 06/2006
3Precision Medicine
01/2022 - 05/2018
3Hematopoietic Stem Cell Transplantation
04/2020 - 01/2018